I Sold Pfizer at a 13% Loss - Here's Why I'm Choosing Stability Over Risk

"Selling shares at a loss can be strategic, especially when a single stock dominates an investment portfolio. In this case, a Reddit user sold Pfizer shares at a 13% loss because it constituted 25% of their portfolio, indicating the need for diversification."

"Pfizer's stock has experienced a decline of about 4% year to date and about 12.5% over the past year, reflecting the challenges that may lead investors to reduce their holdings."

"In investment strategy, there are circumstances where selling at a loss is advantageous. For example, when a stock represents too large a portion of a portfolio, diversifying can mitigate risks."

"Many investors hold onto stocks despite losses, but in instances like this, selling for diversification is a prudent move, particularly when stock price declines like Pfizer's range from 4% to 25% over different periods."

Selling shares at a loss may not be ideal, but there are situations where it is necessary, such as when one stock dominates a portfolio. A Reddit user sold Pfizer shares at a 13% loss because they comprised 25% of their total investment. Pfizer's stock has been on a decline, losing 4% year to date and 12.5% over the past year. Investors often need to reevaluate their portfolios, particularly when certain stocks have lost significant value over time, making diversification a prudent strategy.

Read at 24/7 Wall St.